(August 11, 2023, 10:48 AM EDT) -- WASHINGTON, D.C. — A decision by the Patent Trial and Appeal Board that upheld an examiner’s rejection of an application to patent a way of improving cholesterol efflux activity was vacated Aug. 10 by the Federal Circuit U.S. Court of Appeals....